Correlation Between InnoTherapy and MetaLabs

Can any of the company-specific risk be diversified away by investing in both InnoTherapy and MetaLabs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining InnoTherapy and MetaLabs into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between InnoTherapy and MetaLabs Co, you can compare the effects of market volatilities on InnoTherapy and MetaLabs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in InnoTherapy with a short position of MetaLabs. Check out your portfolio center. Please also check ongoing floating volatility patterns of InnoTherapy and MetaLabs.

Diversification Opportunities for InnoTherapy and MetaLabs

0.63

Correlation Coefficient

InnoTherapy  MetaLabs

Poor diversification

The 3 months correlation between InnoTherapy and MetaLabs is 0.63. Overlapping area represents the amount of risk that can be diversified away by holding InnoTherapy and MetaLabs Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MetaLabs and InnoTherapy is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on InnoTherapy are associated (or correlated) with MetaLabs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MetaLabs has no effect on the direction of InnoTherapy i.e., InnoTherapy and MetaLabs go up and down completely randomly.

Pair Corralation between InnoTherapy and MetaLabs

Assuming the 90 days trading horizon InnoTherapy is expected to generate 0.7 times more return on investment than MetaLabs. However, InnoTherapy is 1.42 times less risky than MetaLabs. It trades about 0.05 of its potential returns per unit of risk. MetaLabs Co is currently generating about -0.25 per unit of risk. If you would invest  821,000  in InnoTherapy on September 1, 2024 and sell it today you would earn a total of  16,000  from holding InnoTherapy or generate 1.95% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

InnoTherapy  vs.  MetaLabs Co

InnoTherapy

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days InnoTherapy has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

MetaLabs

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days MetaLabs Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with InnoTherapy and MetaLabs

The main advantage of trading using opposite InnoTherapy and MetaLabs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if InnoTherapy position performs unexpectedly, MetaLabs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MetaLabs will offset losses from the drop in MetaLabs' long position.

The idea behind InnoTherapy and MetaLabs Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.